Cover Image
市場調查報告書

白樺花粉症:全球臨床實驗檢討

Birch Pollen Allergy Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 316098
出版日期 內容資訊 英文 77 Pages
訂單完成後即時交付
價格
Back to Top
白樺花粉症:全球臨床實驗檢討 Birch Pollen Allergy Global Clinical Trials Review, H2, 2014
出版日期: 2014年09月30日 內容資訊: 英文 77 Pages
簡介

白樺花粉症(白樺花粉過敏)是由於白樺的花粉所引起的過敏反應。

本報告提供白樺花粉症的臨床試驗相關之基本資料和數據,為您彙整實驗數量及受驗者的募集情況,各階段趨勢,進行臨床試驗的主要製藥企業及研究機關簡介等資訊。

簡介

  • 白樺花粉症
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 歐洲主要5個國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量

G7各國臨床實驗數量:免疫疾病治療藥臨床實驗中,白樺花粉症治療藥所佔的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:白樺花粉症治療藥的免疫疾病治療藥臨床實驗中,比率

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

參與白樺花粉症治療藥臨床實驗的主要企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Stallergenes S.A.
    • Merck KGaA
    • Anergis SA
    • Allergy Therapeutics plc
    • HAL Allergy BV
    • ALK-Abello A/S
    • Laboratorios LETI S.L.
    • Marinomed Biotechnologie GmbH
    • E. I. du Pont de Nemours and Company
    • Artu Biologicals
  • 有代表性的研究機關·醫院臨床實驗概要
    • Medical University of Vienna
    • UMC Utrecht Holding BV
    • Royal Sussex County Hospital
    • Oulu University Hospital
    • Sahlgrenska University Hospital
    • Royal Brompton & Harefield NHS Foundation Trust
    • University of Zurich
    • Rijnstate Hospital

5個有代表性的臨床實驗簡介

附錄

目錄

GlobalData's clinical trial report, "Birch Pollen Allergy Global Clinical Trials Review, H2, 2014" provides data on the Birch Pollen Allergy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Birch Pollen Allergy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Birch Pollen Allergy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Birch Pollen Allergy
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
  • Clinical Trials by G7 Countries: Proportion of Birch Pollen Allergy to Immunology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Birch Pollen Allergy to Immunology Clinical Trials
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Birch Pollen Allergy
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Birch Pollen Allergy Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Stallergenes S.A.
      • Clinical Trial Overview of Stallergenes S.A.
      • Merck KGaA
      • Clinical Trial Overview of Merck KGaA
      • Anergis SA
      • Clinical Trial Overview of Anergis SA
      • Allergy Therapeutics plc
      • Clinical Trial Overview of Allergy Therapeutics plc
      • HAL Allergy BV
      • Clinical Trial Overview of HAL Allergy BV
      • ALK-Abello A/S
      • Clinical Trial Overview of ALK-Abello A/S
      • Laboratorios LETI S.L.
      • Clinical Trial Overview of Laboratorios LETI S.L.
      • Marinomed Biotechnologie GmbH
      • Clinical Trial Overview of Marinomed Biotechnologie GmbH
      • E. I. du Pont de Nemours and Company
      • Clinical Trial Overview of E. I. du Pont de Nemours and Company
      • Artu Biologicals
      • Clinical Trial Overview of Artu Biologicals
    • Clinical Trial Overview of Top Institutes / Government
      • Medical University of Vienna
      • Clinical Trial Overview of Medical University of Vienna
      • UMC Utrecht Holding BV
      • Clinical Trial Overview of UMC Utrecht Holding BV
      • Royal Sussex County Hospital
      • Clinical Trial Overview of Royal Sussex County Hospital
      • Oulu University Hospital
      • Clinical Trial Overview of Oulu University Hospital
      • Sahlgrenska University Hospital
      • Clinical Trial Overview of Sahlgrenska University Hospital
      • Royal Brompton & Harefield NHS Foundation Trust
      • Clinical Trial Overview of Royal Brompton & Harefield NHS Foundation Trust
      • University of Zurich
      • Clinical Trial Overview of University of Zurich
      • Rijnstate Hospital
      • Clinical Trial Overview of Rijnstate Hospital
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Birch Pollen Allergy Therapeutics, Global, Clinical Trials by Region, 2014*
  • Birch Pollen Allergy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Birch Pollen Allergy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Birch Pollen Allergy Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Birch Pollen Allergy Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Proportion of Birch Pollen Allergy to Immunology Clinical Trials, G7 Countries (%), 2014*
  • Birch Pollen Allergy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Birch Pollen Allergy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Birch Pollen Allergy to Immunology Clinical Trials, E7 Countries (%), 2014*
  • Birch Pollen Allergy Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Birch Pollen Allergy Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Birch Pollen Allergy Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Birch Pollen Allergy Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Birch Pollen Allergy Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Birch Pollen Allergy Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Birch Pollen Allergy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Birch Pollen Allergy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Birch Pollen Allergy Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Birch Pollen Allergy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Birch Pollen Allergy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Birch Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Stallergenes S.A., 2014*
  • Birch Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck KGaA, 2014*
  • Birch Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Anergis SA, 2014*
  • Birch Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergy Therapeutics plc, 2014*
  • Birch Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by HAL Allergy BV, 2014*
  • Birch Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by ALK-Abello A/S, 2014*
  • Birch Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratorios LETI S.L., 2014*
  • Birch Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Marinomed Biotechnologie GmbH, 2014*
  • Birch Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by E. I. du Pont de Nemours and Company, 2014*
  • Birch Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Artu Biologicals, 2014*
  • Birch Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2014*
  • Birch Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by UMC Utrecht Holding BV, 2014*
  • Birch Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Royal Sussex County Hospital, 2014*
  • Birch Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Oulu University Hospital, 2014*
  • Birch Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Sahlgrenska University Hospital, 2014*
  • Birch Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Royal Brompton & Harefield NHS Foundation Trust, 2014*
  • Birch Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Zurich, 2014*
  • Birch Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Rijnstate Hospital, 2014*

List of Figures

  • Birch Pollen Allergy Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Birch Pollen Allergy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Birch Pollen Allergy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Birch Pollen Allergy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Proportion of Birch Pollen Allergy to Immunology Clinical Trials, G7 Countries (%), 2014*
  • Birch Pollen Allergy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Birch Pollen Allergy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Birch Pollen Allergy to Immunology Clinical Trials, E7 Countries (%), 2014*
  • Birch Pollen Allergy Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Birch Pollen Allergy Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Birch Pollen Allergy Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Birch Pollen Allergy Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Birch Pollen Allergy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Birch Pollen Allergy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Birch Pollen Allergy Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Birch Pollen Allergy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Birch Pollen Allergy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top